semaglutide cardiovascular outcomes news Associated with in Type 2 Diabetes: A Systematic Review and Meta-Analysis Cardiovascular Outcomes, Safety, and Tolerability

Only some GLP-1s are included The covered medications include drugmaker Eli Lillys Foundayo oral tablets and Zepbound KwikPens and Novo Nordisks Wegovy injections and tablets

Epigenetics 14 , 73 (2022)

Obesity: Jastreboff et al., 2023 (NEJM) Jastreboff, Kaplan, Fras, and colleagues reported a phase 2, double-blind, randomized, placebo-controlled trial in the New England Journal of Medicine in 2023 [4]

Remedy's Nutrition Means Results

Cholesterol & Blood Pressure Improvement Studies show that GLP-1 medications lower LDL (bad) cholesterol and triglycerides while promoting healthy levels of HDL (good) cholesterol

When drugs are fast released into the body they may produce severe adverse reactions because their plasmatic concentration may reach high values in a very short time